Maravai Lifesciences Holdings, Inc. (MRVI)
7.90
+0.40
(+5.33%)
USD |
NASDAQ |
Oct 02, 16:00
7.87
-0.03
(-0.38%)
After-Hours: 20:00
Maravai Lifesciences Holdings Cash from Operations (TTM) : -25.26M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.26M |
| March 31, 2026 | -39.52M |
| December 31, 2025 | -57.57M |
| September 30, 2025 | -50.68M |
| June 30, 2025 | -22.40M |
| March 31, 2025 | 5.301M |
| December 31, 2024 | 6.224M |
| September 30, 2024 | 29.89M |
| June 30, 2024 | 30.92M |
| March 31, 2024 | 32.68M |
| Date | Value |
|---|---|
| December 31, 2023 | 126.22M |
| September 30, 2023 | 217.77M |
| June 30, 2023 | 313.66M |
| March 31, 2023 | 458.75M |
| December 31, 2022 | 535.98M |
| September 30, 2022 | 495.38M |
| June 30, 2022 | 490.89M |
| March 31, 2022 | 492.55M |
| December 31, 2021 | 368.57M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Repligen Corp. | 134.86M |
| Bio-Techne Corp. | 292.07M |
| BioLife Solutions, Inc. | 16.88M |
| MindWalk Holdings Corp. | -8.921M |
| MaxCyte, Inc. | -22.98M |